Company: PRTA
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001559053-25-000044
Chunk: 7

Company: PROTHENA CORP PUBLIC LTD CO
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 7
---
 ordinary share                                    $                         ( 0.68)      $           ( 1.10)      $                         ( 4.13)        ( 1.20)  

Potentially issuable ordinary shares were not used in computing diluted net loss per ordinary share as their effect would be anti-dilutive due to the loss recorded during the three and nine months ended September 30, 2025 and 2024, and therefore diluted net loss per share is equal to basic net loss per share.

The equivalent ordinary shares not included in diluted net income (loss) per share because their effect would be anti-dilutive are as follows (in thousands):

                                                 Three Months Ended                                        Nine Months Ended                          
                                                      September 30,                                            September 30,                          
                                                               2025                  2024                               2025                          
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Stock options to purchase ordinary shares                              11,627                11,297                             11,627      11,297  
  Restricted Stock Units (RSU)                                            1,133        24                                          1,133              
  Total                                                                  12,760                11,321                             12,760      11,321  

6. Commitments and Contingencies

Lease Commitments

As ofSeptember 30, 2025, the Company currently has four leases relating to its facilities in the United States and Dublin, Ireland.

Dublin

In June 2021, the Company entered into a lease agreement for office space in Dublin, Ireland, which commenced in August 2021 and had an initial term of one year one year one year

Brisbane Facility

On October 28, 2022, the Company entered into a noncancelable operating sublease (the "Brisbane Sublease") to sublease approximately 31,157 r 28,2022. The Brisbane Sublease provides that the Company's obligation to pay rent commenced on July 1, 2023, which is subject to abatement for the first six months following such date, with the exception of the seventh rent payment that was due upon execution of the Brisbane Sublease. The Company is obligated to make lease payments totaling approximately $ 14.9 3.0

Total operating lease cost for the Brisbane Sublease was $ 0.8 2.4 0.8 2.4 0.8 2.3